Filter
Exclude
Time range
-
Near
๐Ÿงต๐Ÿซโš ๏ธ ๐—ฅ๐—ฆ๐—œ ๐—ฒ๐—ป ๐—ฝ๐—ฎ๐—ฐ๐—ถ๐—ฒ๐—ป๐˜๐—ฒ๐˜€ ๐—ฑ๐—ฒ ๐—ฎ๐—น๐˜๐—ผ ๐—ฟ๐—ถ๐—ฒ๐˜€๐—ด๐—ผ: ๐—ต๐—ผ๐˜† ๐—น๐—ฎ ๐—บ๐—ฒ๐˜๐—ฎ ๐˜†๐—ฎ ๐—ป๐—ผ ๐—ฒ๐˜€ ๐˜€๐—ผ๐—น๐—ผ โ€œ๐—ถ๐—ป๐˜๐˜‚๐—ฏ๐—ฎ๐—ฟ ๐—ฟ๐—ฎฬ๐—ฝ๐—ถ๐—ฑ๐—ผโ€, ๐˜€๐—ถ๐—ป๐—ผ ๐—ถ๐—ป๐˜๐˜‚๐—ฏ๐—ฎ๐—ฟ ๐˜€๐—ถ๐—ป ๐—ฑ๐—ฒ๐˜€๐—ฎ๐˜๐˜‚๐—ฟ๐—ฎ๐—ฟ ๐—ป๐—ถ ๐—ฐ๐—ผ๐—น๐—ฎ๐—ฝ๐˜€๐—ฎ๐—ฟ ๐—ฎ๐—น ๐—ฝ๐—ฎ๐—ฐ๐—ถ๐—ฒ๐—ป๐˜๐—ฒ ๐Ÿšจ @ElsevierConnect @sciencedirect La ๐™๐™Ž๐™„ debe equilibrar 3 objetivos a la vez: โœ… asegurar vรญa aรฉrea โœ… minimizar aspiraciรณn โœ… evitar ๐™๐™ž๐™ฅ๐™ค๐™ญ๐™š๐™ข๐™ž๐™– e ๐™ž๐™ฃ๐™š๐™จ๐™ฉ๐™–๐™—๐™ž๐™ก๐™ž๐™™๐™–๐™™ ๐™๐™š๐™ข๐™ค๐™™๐™ž๐™ฃ๐™–ฬ๐™ข๐™ž๐™˜๐™– ๐Ÿ‘‰ En el paciente crรญtico, muchas veces el mayor peligro no es la aspiraciรณn, sino la ๐™™๐™š๐™จ๐™–๐™ฉ๐™ช๐™ง๐™–๐™˜๐™ž๐™คฬ๐™ฃ ๐™ค ๐™š๐™ก ๐™˜๐™ค๐™ก๐™–๐™ฅ๐™จ๐™ค ๐™˜๐™–๐™ง๐™™๐™ž๐™ค๐™ซ๐™–๐™จ๐™˜๐™ช๐™ก๐™–๐™ง ๐™ฅ๐™š๐™ง๐™ž๐™ž๐™ฃ๐™ฉ๐™ช๐™—๐™–๐™˜๐™ž๐™คฬ๐™ฃ. ๐Ÿง ๐Ÿ“‰ ๐™€๐™ก ๐™™๐™–๐™ฉ๐™ค ๐™ž๐™ฃ๐™˜๐™คฬ๐™ข๐™ค๐™™๐™ค: ๐™ก๐™– ๐™๐™Ž๐™„ ๐™ฉ๐™ž๐™š๐™ฃ๐™š ๐™˜๐™ค๐™ข๐™ฅ๐™ก๐™ž๐™˜๐™–๐™˜๐™ž๐™ค๐™ฃ๐™š๐™จ ๐™˜๐™ค๐™ฃ ๐™ข๐™ช๐™˜๐™๐™– ๐™›๐™ง๐™š๐™˜๐™ช๐™š๐™ฃ๐™˜๐™ž๐™– Casi ๐Ÿฑ๐Ÿฌ% de los pacientes pueden presentar al menos un evento adverso periintubaciรณn ๐Ÿ˜ตโ€๐Ÿ’ซ Los mรกs importantes: ๐Ÿซ€ ๐™ž๐™ฃ๐™š๐™จ๐™ฉ๐™–๐™—๐™ž๐™ก๐™ž๐™™๐™–๐™™ ๐™˜๐™–๐™ง๐™™๐™ž๐™ค๐™ซ๐™–๐™จ๐™˜๐™ช๐™ก๐™–๐™ง ๐Ÿซ ๐™๐™ž๐™ฅ๐™ค๐™ญ๐™š๐™ข๐™ž๐™– ๐™จ๐™š๐™ซ๐™š๐™ง๐™– ๐Ÿ’€ ๐™ฅ๐™–๐™ง๐™ค ๐™˜๐™–๐™ง๐™™๐™ž๐™–๐™˜๐™ค Y algo clave: ๐ŸŽฏ el gran objetivo operativo sigue siendo el ๐™šฬ๐™ญ๐™ž๐™ฉ๐™ค ๐™š๐™ฃ ๐™š๐™ก ๐™ฅ๐™ง๐™ž๐™ข๐™š๐™ง ๐™ฅ๐™–๐™จ๐™š, porque mรบltiples intentos aumentan mucho los eventos adversos. ๐Ÿ’จ๐Ÿซ ๐™‹๐™ง๐™š๐™ค๐™ญ๐™ž๐™œ๐™š๐™ฃ๐™–๐™˜๐™ž๐™คฬ๐™ฃ: ๐™–๐™ฆ๐™ช๐™žฬ ๐™จ๐™š ๐™œ๐™–๐™ฃ๐™–๐™ฃ ๐™ค ๐™จ๐™š ๐™ฅ๐™ž๐™š๐™ง๐™™๐™š๐™ฃ ๐™ข๐™ช๐™˜๐™๐™ค๐™จ ๐™๐™Ž๐™„ El review favorece claramente: โœ… ๐™ซ๐™š๐™ฃ๐™ฉ๐™ž๐™ก๐™–๐™˜๐™ž๐™คฬ๐™ฃ ๐™ฃ๐™ค ๐™ž๐™ฃ๐™ซ๐™–๐™จ๐™ž๐™ซ๐™– (๐™‰๐™„๐™‘) sobre mascarilla facial estรกndar en pacientes de alto riesgo โœ… posiciรณn ๐™จ๐™š๐™ข๐™ž๐™ž๐™ฃ๐™˜๐™ค๐™ง๐™ฅ๐™ค๐™ง๐™–๐™™๐™– cuando sea posible โœ… considerar ๐™ƒ๐™๐™‰๐™Š como complemento, no necesariamente como sustituto en hipoxemia severa Y deja otra idea importante ๐Ÿ‘‡ ๐Ÿ‘‰ la ๐™ซ๐™š๐™ฃ๐™ฉ๐™ž๐™ก๐™–๐™˜๐™ž๐™คฬ๐™ฃ ๐™จ๐™ช๐™–๐™ซ๐™š ๐™˜๐™ค๐™ฃ ๐™—๐™ค๐™ก๐™จ๐™–-๐™ข๐™–๐™จ๐™˜๐™–๐™ง๐™ž๐™ก๐™ก๐™– entre inducciรณn e intubaciรณn puede reducir hipoxemia ๐™จ๐™ž๐™ฃ ๐™–๐™ช๐™ข๐™š๐™ฃ๐™ฉ๐™–๐™ง ๐™–๐™จ๐™ฅ๐™ž๐™ง๐™–๐™˜๐™ž๐™คฬ๐™ฃ en UCI, en pacientes seleccionados. ๐Ÿ“น๐Ÿ› ๏ธ ๐™‘๐™ž๐™™๐™š๐™ค๐™ก๐™–๐™ง๐™ž๐™ฃ๐™œ๐™ค๐™จ๐™˜๐™ค๐™ฅ๐™ž๐™ค ๐™š๐™จ๐™ฉ๐™ž๐™ก๐™š๐™ฉ๐™š: ๐™˜๐™–๐™™๐™– ๐™ซ๐™š๐™ฏ ๐™ข๐™–ฬ๐™จ ๐™š๐™ก ๐™˜๐™ค๐™ข๐™—๐™ค ๐™š๐™จ๐™ฉ๐™–ฬ๐™ฃ๐™™๐™–๐™ง ๐Ÿ“น ๐™ซ๐™ž๐™™๐™š๐™ค๐™ก๐™–๐™ง๐™ž๐™ฃ๐™œ๐™ค๐™จ๐™˜๐™ค๐™ฅ๐™ž๐™ค mejora visualizaciรณn y aumenta el รฉxito al primer intento ๐Ÿงต ๐™š๐™จ๐™ฉ๐™ž๐™ก๐™š๐™ฉ๐™š tambiรฉn mejora el รฉxito del primer intento comparado con tubo solo ๐Ÿ‘‰ Estrategias mรกs recomendadas para reducir complicaciones. En cambio: ๐Ÿšซ ๐™ฅ๐™ง๐™š๐™จ๐™ž๐™คฬ๐™ฃ ๐™˜๐™ง๐™ž๐™˜๐™ค๐™ž๐™™๐™š๐™– ๐™ง๐™ช๐™ฉ๐™ž๐™ฃ๐™–๐™ง๐™ž๐™– ya no sale bien parada: no demuestra beneficio consistente y puede estorbar. ๐Ÿ’‰๐Ÿซ€ ๐™„๐™ฃ๐™™๐™ช๐™˜๐™ฉ๐™ค๐™ง ๐™š๐™ฃ ๐™ž๐™ฃ๐™š๐™จ๐™ฉ๐™–๐™—๐™ก๐™š๐™จ: ๐™š๐™ฉ๐™ค๐™ข๐™ž๐™™๐™–๐™ฉ๐™ค ๐™ฎ ๐™ ๐™š๐™ฉ๐™–๐™ข๐™ž๐™ฃ๐™– ๐™จ๐™ž๐™œ๐™ช๐™š๐™ฃ ๐™–๐™ก ๐™˜๐™š๐™ฃ๐™ฉ๐™ง๐™ค ๐™™๐™š๐™ก ๐™™๐™š๐™—๐™–๐™ฉ๐™š Para pacientes con compromiso hemodinรกmico, el review favorece: โœ… ๐™š๐™ฉ๐™ค๐™ข๐™ž๐™™๐™–๐™ฉ๐™ค โœ… ๐™ ๐™š๐™ฉ๐™–๐™ข๐™ž๐™ฃ๐™– mรกs que propofol Pero hay un matiz muy importante: ๐Ÿ“Œ un ensayo reciente citado en el artรญculo encontrรณ que ๐™ ๐™š๐™ฉ๐™–๐™ข๐™ž๐™ฃ๐™– se asociรณ con ๐™ข๐™–ฬ๐™จ ๐™˜๐™ค๐™ก๐™–๐™ฅ๐™จ๐™ค ๐™˜๐™–๐™ง๐™™๐™ž๐™ค๐™ซ๐™–๐™จ๐™˜๐™ช๐™ก๐™–๐™ง ๐™ฅ๐™š๐™ง๐™ž๐™ž๐™ฃ๐™ฉ๐™ช๐™—๐™–๐™˜๐™ž๐™คฬ๐™ฃ que ๐™š๐™ฉ๐™ค๐™ข๐™ž๐™™๐™–๐™ฉ๐™ค, aunque sin diferencia en mortalidad hospitalaria a 28 dรญas. ๐Ÿ‘‰ Traducciรณn prรกctica: en el paciente ๐™จ๐™šฬ๐™ฅ๐™ฉ๐™ž๐™˜๐™ค ๐™ค ๐™ข๐™ช๐™ฎ ๐™›๐™ง๐™–ฬ๐™œ๐™ž๐™ก ๐™๐™š๐™ข๐™ค๐™™๐™ž๐™ฃ๐™–ฬ๐™ข๐™ž๐™˜๐™–๐™ข๐™š๐™ฃ๐™ฉ๐™š, ๐™š๐™ฉ๐™ค๐™ข๐™ž๐™™๐™–๐™ฉ๐™ค sigue siendo una opciรณn muy fuerte. ๐Ÿšซ๐Ÿ’ง ๐˜ฟ๐™ค๐™จ ๐™ง๐™š๐™›๐™ก๐™š๐™Ÿ๐™ค๐™จ ๐™˜๐™ก๐™–ฬ๐™จ๐™ž๐™˜๐™ค๐™จ ๐™ฆ๐™ช๐™š ๐™š๐™ก ๐™ฅ๐™–๐™ฅ๐™š๐™ง ๐™˜๐™ช๐™š๐™จ๐™ฉ๐™ž๐™ค๐™ฃ๐™–: ๐™›๐™ก๐™ช๐™ž๐™™๐™ค๐™จ ๐™ฅ๐™–๐™ง๐™– ๐™ฉ๐™ค๐™™๐™ค๐™จ ๐™ฎ ๐™ค๐™ฅ๐™ž๐™ค๐™ž๐™™๐™š๐™จ ๐™ฅ๐™ค๐™ง ๐™ง๐™ช๐™ฉ๐™ž๐™ฃ๐™– El review no apoya: ๐Ÿšซ ๐™—๐™ค๐™ก๐™ค ๐™™๐™š ๐™›๐™ก๐™ช๐™ž๐™™๐™ค๐™จ ๐™ง๐™ช๐™ฉ๐™ž๐™ฃ๐™–๐™ง๐™ž๐™ค previo a la intubaciรณn porque ensayos de alta calidad no mostraron reducciรณn de colapso cardiovascular Y tambiรฉn pide cautela con: ๐Ÿ’Š ๐™ค๐™ฅ๐™ž๐™ค๐™ž๐™™๐™š๐™จ y ๐™ข๐™ž๐™™๐™–๐™ฏ๐™ค๐™ก๐™–๐™ข en inestables, por mayor riesgo de hipotensiรณn En cambio, propone pensar en: ๐Ÿซ€ ๐™ซ๐™–๐™จ๐™ค๐™ฅ๐™ง๐™š๐™จ๐™ค๐™ง ๐™ฅ๐™ง๐™ค๐™›๐™ž๐™ก๐™–ฬ๐™˜๐™ฉ๐™ž๐™˜๐™ค ๐™จ๐™š๐™ก๐™š๐™˜๐™ฉ๐™ž๐™ซ๐™ค (fenilefrina o norepinefrina en dosis bajas) en pacientes con poca reserva hemodinรกmica. ๐ŸŽฏ๐Ÿค ๐™๐™–๐™ ๐™š-๐™๐™ค๐™ข๐™š: ๐™ก๐™– ๐™๐™Ž๐™„ ๐™จ๐™š๐™œ๐™ช๐™ง๐™– ๐™™๐™š๐™ฅ๐™š๐™ฃ๐™™๐™š ๐™ฉ๐™–๐™ฃ๐™ฉ๐™ค ๐™™๐™š ๐™›๐™ž๐™จ๐™ž๐™ค๐™ก๐™ค๐™œ๐™žฬ๐™– ๐™ฎ ๐™š๐™ฆ๐™ช๐™ž๐™ฅ๐™ค ๐™˜๐™ค๐™ข๐™ค ๐™™๐™š ๐™›๐™–ฬ๐™ง๐™ข๐™–๐™˜๐™ค๐™จ El cierre del artรญculo es muy bueno ๐Ÿ”ฅ La RSI de alto riesgo hoy exige: ๐Ÿงพ preparaciรณn estructurada ๐Ÿค trabajo en equipo ๐Ÿ“น VL de primera lรญnea ๐Ÿ’จ buena preoxigenaciรณn ๐Ÿ’‰ selecciรณn individualizada de fรกrmacos ๐Ÿซ€ prevenciรณn activa de hipotensiรณn ๐Ÿ‘‰ Antes de inducir, ya debes tener pensados oxigenaciรณn, dispositivo, apoyo hemodinรกmico y plan del primer intento. En otras palabras: ๐™๐™Ž๐™„ ๐™ฎ๐™– ๐™ฃ๐™ค ๐™š๐™จ ๐™จ๐™ค๐™ก๐™ค ๐™ช๐™ฃ๐™– ๐™ฉ๐™šฬ๐™˜๐™ฃ๐™ž๐™˜๐™– ๐™ง๐™–ฬ๐™ฅ๐™ž๐™™๐™–; ๐™š๐™จ ๐™ช๐™ฃ๐™– ๐™š๐™จ๐™ฉ๐™ง๐™–๐™ฉ๐™š๐™œ๐™ž๐™– ๐™˜๐™ค๐™ข๐™ฅ๐™ก๐™š๐™ฉ๐™– ๐™ฅ๐™–๐™ง๐™– ๐™š๐™ซ๐™ž๐™ฉ๐™–๐™ง ๐™™๐™š๐™จ๐™–๐™ฉ๐™ช๐™ง๐™–๐™˜๐™ž๐™คฬ๐™ฃ, ๐™˜๐™ค๐™ก๐™–๐™ฅ๐™จ๐™ค ๐™ฎ ๐™›๐™ง๐™–๐™˜๐™–๐™จ๐™ค ๐™–๐™ก ๐™ฅ๐™ง๐™ž๐™ข๐™š๐™ง ๐™ฅ๐™–๐™จ๐™ค. โ€ผ๏ธSi te sirve: โค๏ธ Me gusta | ๐Ÿ” Repost | โž• Follow para mรกs๐Ÿ‘‡๐Ÿผ๐Ÿ‘‡๐Ÿผ๐Ÿ‘‡๐Ÿผ๐Ÿ‘‡๐Ÿผ ๐Ÿ“š๐Ÿ“–#ClubCrit๐Ÿ‘จ๐Ÿปโ€โš•๏ธ๐Ÿ‘จ๐Ÿปโ€๐Ÿซ๐Ÿง ๐Ÿซถ ๐Ÿ“š๐Ÿ“– Mรกs en el blog ๐Ÿ‘‰ [buff.ly/61OGR7B] #RSI #Airway #FOAMed #FOAMcc #ClubCrit #RSI #FirstPassSuccess #ICUAirway #EmergencyAirway #Preoxygenation #NIV #HFNO #Videolaryngoscopy #Stylet #AirwayManagement #Etomidate #Ketamine #Hemodynamics #PeriIntubationHypotension #Vasopressors #CriticalCare #CriticalCare #CuidadoCrรญtico #MedTwitter #CritCare #icu #intensivecare #diagnosis #management #UCI #MedicinaBasadaEnEvidencia #MedEd #MedX #IntensiveCare #MedIntensiva #MedXCommunity #MedED #ICUmanagement #MustRead #LecturaRecomendada
1
30
104
3,406
Keep an intubation logbook and improve your first pass succes rate for basic and advanced airways ๐Ÿ‘‡๐ŸผThis is how it is done with โ€œMy intubationsโ€ feature of @AirwayTriageApp @jducanto @dave1olvera @HouthoffKavita @dasairway @NaveenEipe @emcrit @SafeAirway @NicholasChrimes @doctimcook @ProfEllenO @wei_huafeng @VirtueOfNothing @altgm #anaesthesia #airwaytriage #airway #firstpasssuccess
4
12
517
#DoTheDropZone at #LINNCParis, June 1โ€“3! ๐Ÿง  Drop Zoneโ„ข technology. Two platforms. Zero compromises. #NeVa โ€“ #FirstPassSuccess across all clot types #NeVaNET โ€“ the only stent retriever with microfiltration @Diane_Demet @LINNConline #stroke
2
4
75
#AINR Vicenza๐Ÿง  #NeVa & #NeVaNET for #FirstPassSuccess. New: #NeVaVS for aSAH vasospasm. NeVa 3mm in pilot. #DoTheDropZone NeVa & NeVa NET are CE-marked; not currently available in the U.S. NeVa VS is FDA-approved, CE Marked for the treatment of cerebral vasospasm due to aSAH.
1
2
109
๐Ÿง  #DoTheDropZone at Congresso #AINR - Neuroradiologia Interventistica, March 22โ€“24. #NeVa & #NeVaNET โ€” built for #FirstPassSuccess in stroke #thrombectomy. ๐Ÿ‘‹ Find Jennifer Geluso on the floor. NeVa & NeVa NET are CE-marked; not currently available in the U.S. #stroke
1
2
62
Vicenza ๐Ÿง  March 22โ€“24. Looking forward to connecting with the neurointerventional community at Congresso AINR - Neuroradiologia Interventistica. #NeVa & #NeVaNET โ€” first-pass success in #stroke thrombectomy. Hope to see you there! #DoTheDropZone #AINR #FirstPassSuccess
1
2
54
#DoTheDropZone at #SFNR2026! ๐Ÿ“ณDM @Diane_Demet or visit our station for #๐—ก๐—ฒ๐—ฉ๐—ฎ โ€“ designed for #FirstPassSuccess with ๐—”๐—Ÿ๐—Ÿ ๐—ฐ๐—น๐—ผ๐˜ ๐˜๐˜†๐—ฝ๐—ฒ๐˜€ Hope to see you there! NeVa is CE-marked and reimbursed in France; not currently available in the U.S. #stroke #thrombectomy
1
2
65
#DoTheDropZone in Prague! Vesalio is excited to support the #EXMINT 8.2 training initiative for ischemic #stroke. Stop by our station for hands-on experience with #NeVa, and updates on #NeVa & #NeVaNET for #FirstPassSuccess in stroke thrombectomy. See you there! @esmintsociety
1
2
48
Excited to be at Rencontres Nationales des Centres de Thrombectomie de Mention A! We're at Booth 13 connecting w/ the neurointerventional community to share updates on #NeVa & #NeVaNET & their role in #FirstPassSuccess for #stroke #thrombectomy. #DoTheDropZone #SFNR @SFNRadio
1
2
58
#DoTheDropZone in Salzburg ๐Ÿง  We look forward to connecting with the neurointerventional community at #IROS2026 this week. Weโ€™ll be sharing the latest updates on #NeVa and #NeVaNET, and how they support #FirstPassSuccess in #stroke thrombectomy. Hope to see you there!
1
3
158
16 Dec 2025
#DoTheDropZone at #ESIR2025 Hands-On Course Join the Vesalio training session to discover all-clot capabilities of โžก๏ธ #NeVa, for achieving impressive #FirstPassSuccess on all clot types โžก๏ธ #NeVaNET, the world's only stent retriever with microfiltration technology See you there!
1
2
55
2 Dec 2025
#DoTheDropZone at #BRAINConference๐ŸŽ„ TOMORROW ๐Ÿ“… Dec 3, 15:05โ€“15:20 โ€œNeVa โ€“ The Story So Farโ€ w/ @drpaulbhogal Visit our booth or DM @Diane_Demet for ๐Ÿง  #NeVa, #FirstPassSuccess on ALL clots ๐Ÿง  #NeVaNET, Only stent retriever w/ microfiltration See you there! @EdenMoe
2
2
188
25 Nov 2025
#DoTheDropZone at #ESNR! Weโ€™re excited to join the INR community for impactful sessions and the ECINR 4-1 Stroke Module Let's connect โžก๏ธ DM @Diane_Demet ๐Ÿง  #NeVa for #FirstPassSuccess on all clot types ๐Ÿง  #NeVaNET only stent retriever w/ microfiltration technology See you there!
1
3
68
12 Nov 2025
#DoTheDropZone at #BRAINConference in London! Plan to stop by our booth or DM @Diane_Demet for: ๐Ÿง  #NeVa: #FirstPassSuccess on ALL clots ๐Ÿง  #NeVaNET: World's only stent retriever with microfiltration for max clot retention See you there! @brainconferenc1
2
4
134
9 Oct 2025
Vesalio is thrilled to be in Buenos Aires for #CANI2025! Weโ€™re eager to reconnect with our Drop Zone adepts & meet new professionals interested in discovering #FirstPassSuccess with #NeVa & #NeVaNET! Are you there? Please stop by. Hope to see you there! #DoTheDropZone
1
3
70
29 Aug 2025
๐ŸŒ Vesalio is excited for #ESMINT2025, 3โ€“6 Sep in Marseille! ๐Ÿ“ Booth 13 to catch up & see whatโ€™s new: ๐Ÿง  #NeVa โ€“ for high #FirstPassSuccess on all clot types ๐Ÿง  #NeVaNET โ€“ the only stent retriever with microfiltration tech to maximize clot retention See you there! @esmintsociety
1
3
91
3 Jun 2025
#DoTheDropZone at #LINNCParis! Please stop by to say hello & learn about Drop Zoneโ„ข technology โžก๏ธ #NeVa โ€“ delivering #FirstPassSuccess across all clot types โžก๏ธ #NeVaNET โ€“ the worldโ€™s only stent retriever with microfiltration technology ๐Ÿ“ณ DM @Diane_Demet @LINNConline #stroke
3
2
279
30 May 2025
#DoTheDropZone next week at #LINNCParis! Contact us for designed with Drop Zoneโ„ข technology โžก๏ธ #NeVa โ€“ delivering #FirstPassSuccess across all clot types โžก๏ธ #NeVaNET โ€“ the worldโ€™s only stent retriever with microfiltration technology ๐Ÿ“ณ DM @Diane_Demet @LINNConline #stroke
1
3
81
26 May 2025
#DoTheDropZone in Amsterdam! Proud to partner with @esmintsociety for this week's ESMINT Skills Training. Designed with Drop Zoneโ„ข Technology โžก๏ธ #NeVa โ€“ for #FirstPassSuccess across all clot types โžก๏ธ #NeVaNET โ€“ only stent retriever with microfiltration technology @Diane_Demet
1
3
92
15 May 2025
#DoTheDropZone in Colombia! Weโ€™re at #CCR2025 in Cartagena, sharing the latest innovation in #stroke and #vasospasm care. DM @JAntonio2105 to explore: โžก๏ธ #NeVa โ€“ exceptional #FirstPassSuccess โžก๏ธ #NeVaNET โ€“ stent retriever with microfiltration โžก๏ธ #NeVaVS โ€“ for post-aSAH vasospasm
1
2
2
78